Why the National Veterinary Care Ltd share price is a big opportunity

Credit: Michael Gil

The National Veterinary Care Ltd (ASX: NVL) share price has grown by 24% over the past year. I think there’s a lot more growth come for the following reasons:


National Vet Care’s key route to growth is more veterinary clinics.

It acquired 14 clinics during FY17 and there are a number of potential targets in the pipeline.

National Vet Care could go on to grow its total clinic number up to 150, 200 or even more. There is plenty of growth left for the business.

Increasing margins

As the business gets bigger its profit margins naturally get bigger as its economies of scale comes into play.

During FY17 it grew its underlying earnings before interest, tax, depreciation and amortisation margin from 17.4% to 18.1%. This could grow further as the years go by, accelerating growth.

Pet population growth

The Australian pet population is steadily growing alongside the human population.

This growth is causing a boom in the pet industry and adding significant revenue potential for both National Vet Care and Greencross Limited (ASX: GXL).

If people continue to treat their pets as furry children then veterinary clinics should be a good growth industry.

Foolish takeaway

National Vet Care is currently trading at 32x FY17’s earnings with a grossed-up dividend yield of 1.6%. Management expect statutory revenue growth to be in the region of 25%, which means National Vet Care could have another good year. I think it’s a buy at the current price.

Other growth shares I think are buys are these top hot stocks for 2017.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Greencross Limited and NATVETCARE FPO. The Motley Fool Australia owns shares of Greencross Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.